Osteopetrosis.

Area of Science:

• Genetics and Skeletal Biology

Background:

• Osteopetrosis, or "marble bone disease," is a group of rare, heritable skeletal disorders characterized by increased bone density.
• Incidence varies, with autosomal recessive osteopetrosis (ARO) at 1 in 250,000 births and autosomal dominant osteopetrosis (ADO) at 1 in 20,000 births.
• Severity ranges from life-threatening neonatal onset (classic ARO) to incidental radiographic findings (osteopoikilosis).

Purpose of the Study:

• To review the clinical presentation, genetic basis, diagnosis, and treatment of osteopetrosis.
• To highlight the varying severity and inheritance patterns of osteopetrotic conditions.

Main Methods:

• Diagnosis relies on clinical and radiographic evaluation.
• Genetic testing confirms diagnosis in applicable cases.
• Review of natural history, treatment options, and recurrence risks.

Main Results:

• Classic ARO presents with fractures, short stature, neuropathies, hypocalcemia, and pancytopenia.
• ADO typically manifests with fractures and osteomyelitis in late childhood/adolescence.
• Mutations in at least 10 genes cause 70% of osteopetrosis cases, with autosomal recessive forms being most severe.

Conclusions:

• Osteopetrosis results from osteoclast dysfunction, with diverse genetic causes and clinical outcomes.
• Symptomatic treatment is standard, while hematopoietic stem cell transplantation offers the best survival chance for severe, bone marrow failure-associated forms.
• Further research into molecular pathogenesis may reveal new therapeutic targets.